Baudax Bio ROCE Ratio 2011-2026 | BXRX

Annual ROCE Ratio Baudax Bio

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
234.36	-143.7	-110.28	-101.23	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
234.36	-143.7	-30.21

Quarterly ROCE Ratio Baudax Bio

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
162.21	159.66	4.4	-152.74	-73.72	-9.48	436.6	2077.87	2160.72	2164.56	2012.05	559.69	621.16	599.77	458.7	150.39	150.39	88.92	25.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2164.56	-152.74	610.36

ROCE Ratio of other stocks in the Biotechnology industry

Issuer	ROCE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	2.89	-	2.43 %	$ 254 M	Germany
Altimmune ALT	-42.02	$ 3.41	2.1 %	$ 300 M	USA
Amgen AMGN	104.87	$ 350.17	0.68 %	$ 188 B	USA
Amphastar Pharmaceuticals AMPH	17.8	$ 19.57	0.36 %	$ 915 M	USA
Alexion Pharmaceuticals, Inc. ALXN	17.36	-	-	$ 40.3 B	USA
Genfit SA GNFT	-49.48	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-325.06	-	-13.47 %	$ 169 M	France
Ascendis Pharma A/S ASND	-45.89	$ 217.82	-1.83 %	$ 5 B	Danmark
Autolus Therapeutics plc AUTL	-161.2	$ 1.4	1.82 %	$ 357 M	Britain
Midatech Pharma plc MTP	-337.43	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-61.36	-	-1.52 %	$ 24.7 M	USA
Aytu BioScience AYTU	-12.81	$ 2.64	1.15 %	$ 16.6 M	USA
Applied Genetic Technologies Corporation AGTC	-60.13	-	-	$ 26.5 M	USA
ARCA biopharma ABIO	-23.06	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	-29.95	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-180.78	-	-10.17 %	$ 12.2 K	USA
Benitec Biopharma BNTC	-10.11	$ 11.0	0.18 %	$ 453 M	USA
Acorda Therapeutics ACOR	167.74	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	-70.32	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	-119.71	-	10.36 %	$ 9.8 M	USA
Acasti Pharma ACST	-25.04	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	15.18	-	-	-	Russia
Avenue Therapeutics ATXI	-403.4	-	-52.27 %	$ 4.45 M	USA
Adverum Biotechnologies ADVM	-196.79	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	146.85	-	2.71 %	$ 14 M	USA
Advaxis ADXS	429.74	-	-9.65 %	$ 45.9 M	USA
Coherus BioSciences CHRS	-296.87	$ 1.58	3.62 %	$ 185 M	USA
Cellectis S.A. CLLS	-20.47	$ 3.35	0.3 %	$ 116 M	France
Ayala Pharmaceuticals AYLA	3412.47	-	-	$ 7.46 M	Israel
Cullinan Management CGEM	-59.12	$ 12.83	0.71 %	$ 773 M	USA
Atreca BCEL	-34.9	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	19.77	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	7.03	-	0.49 %	$ 251 B	Cayman-islands
Calithera Biosciences CALA	-1377.15	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	-212.83	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-45.41	-	-	$ 3.74 B	USA
Bellerophon Therapeutics BLPH	-883.35	-	-74.18 %	$ 955 K	USA
CorMedix CRMD	37.04	$ 6.29	0.64 %	$ 453 K	USA
CytomX Therapeutics CTMX	-22.59	$ 4.41	-1.01 %	$ 608 M	USA
Checkpoint Therapeutics CKPT	444.94	-	-	$ 169 M	USA
Clovis Oncology CLVS	80.97	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	-29.3	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	-51.5	-	-	$ 867 M	Germany
Compugen Ltd. CGEN	23.38	$ 2.12	1.2 %	$ 198 M	Israel
Denali Therapeutics DNLI	-39.63	$ 20.92	3.69 %	$ 3.44 B	USA
Dyadic International DYAI	-140.0	$ 0.89	-5.85 %	$ 25.6 M	USA
Akero Therapeutics AKRO	-38.05	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	-73.67	$ 4.26	0.47 %	$ 707 M	Canada
Akouos AKUS	-37.16	-	0.23 %	$ 488 M	USA